- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05208151
Creative Drama in Physiotherapy and Rehabilitation Education
June 15, 2022 updated by: Nuray Alaca, Acibadem University
The Perceived Effect of Communication Skills Education Integrated With Creative Drama on Physiotherapy and Rehabilitation Students' Empathy and Communication Skills to Develop With the Patient: A Randomized Controlled Study
Candidates who will provide the health services of the future should be ready to provide the safe and best health care services.
In order to achieve this, it is recommended to use new training programs and methods that will provide similar situations to the working environment in the training of health workers.
There are very few studies on the empathy and communication perceptions that creative drama education will create with the patient on physiotherapy and rehabilitation department students.
Therefore, this study, the investigators aimed to investigate the perceived effect of communication skills training integrated with creative drama on physiotherapy and rehabilitation students' empathy and communication skills that will develop with the patient.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey, +90
- Acıbadem University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being willing to take FZT 233 Effective Communication with Creative Drama in Health course in any of the fall or spring semesters.
Exclusion Criteria:
Desire to take FZT 233 Effective Communication with Creative Drama in Health course at his own request.
- Not wanting to participate in the study
- Having a diagnosed psychological disorder and/or receiving psychological treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
|
|
Active Comparator: Creative Drama Group
|
Effective Communication with Creative Drama in Health Course will be given to students for 2 hours a week for 14 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
interpersonal communication questionnaire
Time Frame: Change from Baseline interpersonal communication questionnaire at 14 weeks
|
It is stated that the first four items are related to communication anxiety and the last four items are related to communication trust.
Each item has a 5-point Likert scale between 1 = strongly disagree 5 = strongly agree.
High values indicate poor communication
|
Change from Baseline interpersonal communication questionnaire at 14 weeks
|
Jefferson Doctor Empathy Scale
Time Frame: Change from Baseline Jefferson Doctor Empathy Scale at 14 weeks
|
The score range is 20-140, with higher average scores representing higher levels of empathy.
|
Change from Baseline Jefferson Doctor Empathy Scale at 14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual analog scale-communication
Time Frame: Change from Baseline Visual analog scale at 14 weeks
|
A visual analog scale between 0 and 10 will be used to evaluate the communication that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient.
Zero will be set to none, 10 will be set to the maximum I can think of.
|
Change from Baseline Visual analog scale at 14 weeks
|
Visual analog scale-anxiety/stress
Time Frame: Change from Baseline Visual analog scale at 14 weeks
|
A visual analog scale between 0 and 10 will be used to evaluate the anxiety/stress that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient.
Zero will be set to none, 10 will be set to the maximum I can think of.
|
Change from Baseline Visual analog scale at 14 weeks
|
Visual analog scale-motivation
Time Frame: Change from Baseline Visual analog scale at 14 weeks
|
A visual analog scale between 0 and 10 will be used to evaluate the motivation that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient.
Zero will be set to none, 10 will be set to the maximum I can think of.
|
Change from Baseline Visual analog scale at 14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 16, 2021
Primary Completion (Actual)
January 15, 2022
Study Completion (Actual)
February 15, 2022
Study Registration Dates
First Submitted
December 28, 2021
First Submitted That Met QC Criteria
January 12, 2022
First Posted (Actual)
January 26, 2022
Study Record Updates
Last Update Posted (Actual)
June 16, 2022
Last Update Submitted That Met QC Criteria
June 15, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ATADEK-2021/22/06
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Educational Problems
-
Stanford UniversityNot yet recruitingEducational Problems
-
Tokat Gaziosmanpasa UniversityCompleted
-
Sakarya UniversityCompleted
-
Sakarya UniversityCompleted
-
European e-Learning School in Obstetric AnesthesiaFondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling by invitationEducational ProblemsItaly
-
Pamukkale UniversityCompleted
-
IlumensCompletedEducational ProblemsFrance
-
Ege UniversityCompleted
-
Selcuk UniversityCompletedEducational ProblemsTurkey
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompleted
Clinical Trials on Creative Drama Education
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Jiaxing ZhouActive, not recruiting
-
Abant Izzet Baysal UniversityRecruitingAddiction | Violence | Men | Woman AbuseTurkey
-
Abant Izzet Baysal UniversityNot yet recruitingEducation | Nurse's Role | Mental Health LiteracyTurkey
-
Abant Izzet Baysal UniversityCompleted
-
VA Office of Research and DevelopmentActive, not recruitingQuality of Life | Parkinson's Disease | Mindfulness Based Stress ReductionUnited States
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongCompleted
-
Yale UniversityEmpowerment to Heal - Uganda; Empower Through HealthRecruiting
-
University of UtahCompleted
-
University of UtahCompleted